Everforth Inc annual report, Q4 FY2000

Business Context and Reporting Period

Company: On Assignment, Inc. (Note: Input metadata referenced "Everforth Inc," but the filing text identifies the registrant as On Assignment, Inc.)
Filing Type: Form 10-K Annual Report
Period Ended: December 31, 2000
Business Overview: A leading nationwide provider of temporary scientific and healthcare professionals. The company operates through two segments: Lab Support (scientific, environmental, and laboratory professionals) and Healthcare Staffing (medical billing, clinical lab, and medical staffing). As of year-end 2000, the company served 82 markets through 176 branch offices, including recent international expansions into the UK, Netherlands, Belgium, and Switzerland.

Key Financial Metrics (Year Ended Dec 31, 2000)

Metric 2000 1999
Revenues $195,080,000 $159,473,000
Cost of Services $131,351,000 $107,652,000
Gross Profit $63,729,000 $51,821,000
Gross Margin 32.7% 32.5%
Operating Income $28,197,000 $21,393,000
Net Income $19,247,000 $14,462,000
Diluted EPS $0.83 $0.65
Cash & Equivalents $51,202,000 $24,120,000
Working Capital $84,717,000 $54,769,000
Total Assets $105,556,000 $71,740,000
Long-term Debt $0 $0

Material Changes vs. Prior Period

  • Revenue Growth: Total revenue increased 22.3% year-over-year. The Healthcare Staffing segment drove significant growth with a 38.4% increase, while Lab Support grew 17.0%.
  • Profitability: Net income rose 33.1% to $19.2 million. Operating income increased 31.8%.
  • Cost Structure: Cost of services increased 22.0%, tracking closely with revenue. Gross margin improved slightly due to a decrease in temporary employee compensation costs in the Lab Support segment, partially offset by increased workers' compensation claims.
  • Liquidity: Cash and cash equivalents more than doubled to $51.2 million, driven by strong operating cash flows ($21.4 million) and proceeds from stock option exercises ($8.6 million).
  • Segment Performance: Healthcare Staffing revenue grew primarily due to a 36% increase in the number of temporary employees on assignment. Lab Support revenue growth was driven by a 10.6% increase in employees on assignment.

Outlook, Risks, and Management Commentary

  • Expansion Strategy: Management plans to continue expanding internationally in Europe and domestically in laboratory, clinical, and medical billing fields. The company intends to apply its "Account Manager System" to new professional fields.
  • Seasonality: Results are subject to seasonal declines during the year-end holiday season through February and during summer months (June-August).
  • Key Risks:
    • Account Manager Dependency: Success relies heavily on recruiting and retaining qualified Account Managers.
    • International Operations: New European operations face risks regarding currency fluctuations, regulatory changes, and limited local experience.
    • Workers' Compensation: The company is partially self-insured; increased claims could materially impact profitability.
    • Competition: The industry is highly competitive with low barriers to entry; major competitors include Manpower, Kelly Services, and Adecco.
  • Management Changes: CEO H. Tom Buelter announced his intention to retire in 2001 once a successor is hired. Dr. Volkmar G. Hable was hired as Executive Vice President, Operations in March 2001.

Investor Verification Checklist

  • Workers' Compensation Reserves: Verify the adequacy of the $1.75 million liability reserve for workers' compensation claims, as the company is partially self-insured and claims increased in 2000.
  • International Integration: Monitor the profitability and integration progress of new subsidiaries in the Netherlands, Belgium, and Switzerland established in 2000.
  • CEO Succession: Track the timeline and selection of the successor to CEO H. Tom Buelter, whose retirement was announced in February 2001.
  • Stock-Based Compensation: Review the impact of stock option exercises on cash flow and the potential dilution from the 2.37 million options outstanding as of year-end 2000.
  • Client Concentration: Confirm that no single client represents a material portion of revenue, given the company serves approximately 6,000 clients.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.